Physician profile
Ted A Mcelroy
NPI 1518959352
$6,279.36
in general payments reported to CMS, 2019-2025
13 companies · $300 in 2025
The $300 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,689 · 2020: $310 · 2021: $195 · 2022: $554 · 2023: $1,889 · 2024: $342 · 2025: $300.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,316 · Travel and Lodging: $1,178 · Entertainment: $37.30.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,315.70 |
| Travel and Lodging | $1,177.90 |
| Entertainment | $37.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,664.16 | 2021-2025 | Air Optix, Dailies Aqua Comfort Plus, Dailies Total1 Multifocal |
| Optos, INC. | $1,390.69 | 2019-2023 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $1,158.98 | 2019-2021 | |
| Coopervision INC. | $557.34 | 2019-2025 | Myday Contact Lens, Misight Contact Lens, Clariti Contact Lens |
| Bausch & Lomb Americas INC. | $145.62 | 2022-2025 | Infuse |
| Abbvie INC. | $72.88 | 2022 | |
| Shire North American Group INC | $65.96 | 2019 | |
| Synergeyes, INC. | $61.91 | 2019 | |
| Lkc Technologies, INC. | $59.45 | 2023 | |
| Lombart Brothers, INC. | $40.00 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $31.66 | 2025 | Xdemvy |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Maculogix, INC. | $11.31 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ted Mcelroy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.